Commonwealth Equity Services
PRME icon

Commonwealth Equity Services’s Prime Medicine PRME Stock Holding History

Commonwealth Equity Services’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
87,310
+70,873
+431% +$235K ﹤0.01% 3709
2026
Q1 		$57.2K Sell
16,437
-17,962
-52% -$68.4K ﹤0.01% 4190
2025
Q4 		$119K Sell
34,399
-28,769
-46% -$128K ﹤0.01% 4085
2025
Q3 		$350K Buy
63,168
+48,226
+323% +$196K ﹤0.01% 3501
2025
Q2 		$37K Buy
+14,942
New +$23K ﹤0.01% 4188

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Commonwealth Equity Services's PRME Position: Q2 2026 in Review

Commonwealth Equity Services increased its Prime Medicine (PRME) stake by 431% in Q2 2026, buying an estimated $235K and bringing the position to 87,310 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #3709.

Commonwealth Equity Services first reported a position in PRME in Q2 2025 and has held it in 5 quarters since. The position peaked at $350K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Commonwealth Equity Services held 87,310 shares of Prime Medicine worth $322K as of Q2 2026.
  • Commonwealth Equity Services bought 70,873 Prime Medicine shares in Q2 2026, an estimated $235K.
  • Prime Medicine made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3709 holding.
  • Commonwealth Equity Services first reported a position in Prime Medicine in Q2 2025 and has held it in 5 quarters since.
  • Commonwealth Equity Services's Prime Medicine position peaked at $350K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.